It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Exosomes are promising disease diagnostic markers and drug delivery vehicles, although their use in practice is limited by insufficient homogeneous quantities that can be produced. We reveal that exposing cells to high frequency acoustic irradiation stimulates their generation without detriment to cell viability by exploiting their innate membrane repair mechanism, wherein the enhanced recruitment of calcium ions from the extracellular milieu into the cells triggers an ESCRT pathway known to orchestrate exosomal production. Given the high post-irradiation cell viabilities (≈95%), we are able to recycle the cells through iterative irradiation and post-excitation incubation steps, which facilitate high throughput production of a homogeneous population of exosomes—a particular challenge for translating exosome therapy into clinical practice. In particular, we show that approximately eight- to ten-fold enrichment in the number of exosomes produced can be achieved with just 7 cycles over 280 mins, equivalent to a yield of around 1.7–2.1-fold/h.
Ambattu et al. report that high frequency acoustic stimulation of mammalian cancer cells promotes exosome generation without affecting cell viability. Acoustic stimulation increases calcium ion influx which triggers an ESCRT pathway related to exosome production. This method may allow for large-scale exosome production with potential clinical applications.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



1 RMIT University, Micro/Nanophysics Research Laboratory, School of Engineering, Melbourne, Australia (GRID:grid.1017.7) (ISNI:0000 0001 2163 3550)
2 RMIT University, RMIT Microscopy and Microanalysis Facility, Melbourne, Australia (GRID:grid.1017.7) (ISNI:0000 0001 2163 3550)
3 The University of Melbourne, Advanced Microscopy Facility, Bio21 Molecular Science & Biotechnology Institute, Parkville, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X)
4 Shanghai Jiao Tong University, School of Biomedical Engineering & Med-X Research Institute, Shanghai, China (GRID:grid.16821.3c) (ISNI:0000 0004 0368 8293)